缅北强奸

Home

听

The Neuro is patient care, Open Science research and training.

ALS Awareness Month 鈥� June 2016

Published: 13 June 2016

The Neuro is recognized as a major Canadian center for ALS research and patient care. During June, designated ALS Month, The Neuro redoubles its efforts to inform the public and the media about...

MNI researchers receive funding to study ARSACS

Published: 24 November 2016

Two researchers at the Montreal Neurological Institute and Hospital (MNI) of 缅北强奸 have received funding to study a devastating neurodegenerative disease that first appears in toddlers...

The Neuro and Thermo Fisher Scientific Partner to Fight Neurodegenerative Disease

Published: 5 March 2018

Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research

Opinion: scientists need to demand better antibody validation

22 Oct 2019

My lab has developed a protocol to easily assess the specificity of antibodies鈥攁nd hopefully stem some of the reproducibility crisis

Improving research with more effective antibodies

Published: 15 October 2019

Scientists demonstrate flaws in protein detection tools, and outline a solution ...

Understanding synaptic genes

4 Jun 2019

International collaboration reveals important characteristics of neuron connectors

Epileptic encephalopathy linked to protein trafficking gene

Published: 28 November 2016

Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells.

Pages

Subscribe to Peter McPherson RSS

The Neuro logo听缅北强奸 logo

听

The Neuro (Montreal Neurological Institute-Hospital)听is a bilingual academic healthcare institution. We are a听缅北强奸 research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the 缅北强奸 Health Centre.听We are听proud to be a Killam Institution, supported by the Killam Trusts.

听

听

Back to top